2021-2022 Regular Session • North Carolina Legislature
H642
Legislative Summary
Down Syndrome Organ Trans. Nondiscrim. Act
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
4/21/2021
Filed
House of Representatives
4/26/2021
Passed 1st Reading
House of Representatives
4/26/2021
Ref to the Com on Health, if favorable, Rules, Calendar, and Operations of the House
House of Representatives
5/11/2021
Reptd Fav Com Substitute
House of Representatives
5/11/2021
Re-ref Com On Rules, Calendar, and Operations of the House
House of Representatives
5/11/2021
Reptd Fav
House of Representatives
5/11/2021
Cal Pursuant Rule 36(b)
House of Representatives
5/11/2021
Added to Calendar
House of Representatives
5/11/2021
Passed 2nd Reading
House of Representatives
5/11/2021
Passed 3rd Reading
House of Representatives
5/12/2021
Regular Message Sent To Senate
House of Representatives
5/12/2021
Regular Message Received From House
Senate
5/12/2021
Passed 1st Reading
Senate
5/12/2021
Ref To Com On Rules and Operations of the Senate
Senate
5/27/2021
Withdrawn From Com
Senate
5/27/2021
Re-ref to Health Care. If fav, re-ref to Rules and Operations of the Senate
Senate
6/1/2021
Withdrawn From Com
Senate
6/1/2021
Re-ref to Health Care. If fav, re-ref to Judiciary. If fav, re-ref to Rules and Operations of the Senate
Senate
6/2/2021
Reptd Fav
Senate
6/2/2021
Re-ref Com On Judiciary
Senate
6/9/2021
Reptd Fav Com Substitute
Senate
6/9/2021
Com Substitute Adopted
Senate
6/9/2021
Re-ref Com On Rules and Operations of the Senate
Senate
6/14/2021
Reptd Fav
Senate
6/15/2021
Passed 2nd Reading
Senate
6/15/2021
Passed 3rd Reading
Senate
6/17/2021
Regular Message Sent To House
Senate
6/17/2021
Regular Message Received For Concurrence in S Com Sub
House of Representatives
6/21/2021
Cal Pursuant 36(b)
House of Representatives
6/21/2021
Placed On Cal For 06/22/2021
House of Representatives
6/22/2021
Concurred In S Com Sub
House of Representatives
6/22/2021
Ordered Enrolled
House of Representatives
6/23/2021
Ratified
6/24/2021
Pres. To Gov. 6/24/2021
7/1/2021
Signed by Gov. 7/1/2021
7/1/2021
Ch. SL 2021-64
Amendments
Senate Proposed Committee Substitute CS: PCS40634-TU-14
Senate Proposed Committee Substitute CS: PCS40634-TU-14
6/9/2021Not Adopted
House Proposed Committee Substitute CS: PCS30413-BP-13
House Proposed Committee Substitute CS: PCS30413-BP-13
5/11/2021Not Adopted
Roll Call Votes
M11 Concur
6/22/2021
110
Yea
0
Nay
0
Not Voting
10
Absent
Result: PASSED
Second Reading
6/15/2021
50
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Second Reading
5/11/2021
111
Yea
0
Nay
1
Not Voting
8
Absent
Result: PASSED
Status Information
Current Status
Passed(7/1/2021)
Chamber
House of Representatives
Sine Die
Sponsors
Republican: 14
Democrat: 22
Primary Sponsor

John Bradford
Republican
Co-Sponsors (35)
Donny Lambeth
Republican
Michael Wray
Democrat
Patricia McElraft
Republican
Johnnie Autry
Democrat
Kristin Baker
Republican
Cynthia Ball
Democrat
Mary Belk
Democrat
Cecil Brockman
Democrat
Terry Brown
Democrat
Deb Butler
Democrat
Becky Carney
Democrat
Mike Clampitt
Republican
George Cleveland
Republican
Carla Cunningham
Democrat
John Faircloth
Republican
Susan Fisher
Democrat
Rosa Gill
Democrat
Charles Graham
Democrat
Wesley Harris
Democrat
Mary Harrison
Democrat
Zack Forde-Hawkins
Democrat
Howard Hunter
Democrat
Verla Insko
Democrat
Carolyn Logan
Democrat
Marvin Lucas
Democrat
Timothy Moffitt
Republican
Ben Moss
Republican
Garland Pierce
Democrat
Larry Pittman
Republican
Mark Pless
Republican
Amos Quick
Democrat
Dennis Riddell
Republican
Raymond Smith
Democrat
Larry Strickland
Republican
Donna White
Republican